Intraperitoneal Lidocaine in Ovarian Cancer Surgery

NANot yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 18, 2022

Primary Completion Date

July 30, 2024

Study Completion Date

July 30, 2029

Conditions
Ovarian CancerPost Operative Pain
Interventions
PROCEDURE

intraperitoneal lidocaine analgesic or normal saline as control

Before the end of surgery, patients in the experimental group (L group) were extensively sprayed with 20mL (100mg) 0.5% lidocaine intraperitoneally before the peritoneum was sutured. The surgeon placed intraperitoneal catheter with the catheter tip above the vaginal end while placing percutaneous drainage tube. The intraperitoneal catheter was connected to the electronic analgesia pump, and the infusion of 0.5% lidocaine 10mL/h was interrupted from 1 to 72h after surgery, with a total volume of 720mL in the pump.

Trial Locations (1)

100191

Peking University Third Hospital, Beijing

All Listed Sponsors
lead

Peking University Third Hospital

OTHER

NCT05450055 - Intraperitoneal Lidocaine in Ovarian Cancer Surgery | Biotech Hunter | Biotech Hunter